Trial Profile
Efficacy and safety of MD1003 in patients with progressive multiple sclerosis : a prospective, observational, single centre study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2020
Price :
$35
*
At a glance
- Drugs Biotin (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 29 Oct 2018 New trial record
- 12 Oct 2018 Results presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis